Effect of the Liraglutide on Automated Closed-Loop Glucose Control in Type 1 Diabetes


Type 1 Diabetes

What is the purpose of this trial?

"Closed loop artificial pancreas" systems have been under development for the control of blood sugars in those living with diabetes. These systems consist of a continuous glucose sensor, which sends a signal to a computer program that automatically determines how much insulin to give. The computer program then tells an insulin pump to deliver the insulin. While such systems have been tested under a number of conditions, post-meal blood sugars are difficult to control. This study is designed to see if liraglutide, a glucagon like peptide receptor agonist, can help minimize the post meal blood sugar spikes in subjects with type 1 diabetes while they are on a closed loop system.

Participation Guidelines

18 Years - 40 Years

Click here for detailed information about who can participate in this trial.

Juvenile Diabetes Research Foundation International
Last Updated:
Study HIC#: